LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | XMD16-144 | 0.37 | uM | LJP5 | 3 | M10 | 72 | hr | 765 | 846 | 3152 | 0.2684 | 0.0505 |
Hs 578T | XMD16-144 | 1.11 | uM | LJP5 | 1 | M09 | 72 | hr | 765 | 808 | 3140 | 0.2573 | 0.0272 |
Hs 578T | XMD16-144 | 1.11 | uM | LJP5 | 2 | M09 | 72 | hr | 765 | 860 | 3151 | 0.2729 | 0.0590 |
Hs 578T | XMD16-144 | 1.11 | uM | LJP5 | 3 | M09 | 72 | hr | 765 | 797 | 3152 | 0.2528 | 0.0202 |
Hs 578T | XMD16-144 | 3.33 | uM | LJP5 | 1 | M08 | 72 | hr | 765 | 658 | 3140 | 0.2095 | -0.0713 |
Hs 578T | XMD16-144 | 3.33 | uM | LJP5 | 2 | M08 | 72 | hr | 765 | 652 | 3151 | 0.2069 | -0.0753 |
Hs 578T | XMD16-144 | 3.33 | uM | LJP5 | 3 | M08 | 72 | hr | 765 | 718 | 3152 | 0.2278 | -0.0306 |
Hs 578T | XMD16-144 | 10 | uM | LJP5 | 1 | M07 | 72 | hr | 765 | 342 | 3140 | 0.1089 | -0.3265 |
Hs 578T | XMD16-144 | 10 | uM | LJP5 | 2 | M07 | 72 | hr | 765 | 349 | 3151 | 0.1107 | -0.3191 |
Hs 578T | XMD16-144 | 10 | uM | LJP5 | 3 | M07 | 72 | hr | 765 | 392 | 3152 | 0.1244 | -0.2792 |
Hs 578T | Erlotinib | 0.04 | uM | LJP5 | 1 | M24 | 72 | hr | 765 | 3118 | 3140 | 0.9929 | 0.9930 |
Hs 578T | Erlotinib | 0.04 | uM | LJP5 | 2 | M24 | 72 | hr | 765 | 3182 | 3151 | 1.0096 | 1.0094 |
Hs 578T | Erlotinib | 0.04 | uM | LJP5 | 3 | M24 | 72 | hr | 765 | 3048 | 3152 | 0.9669 | 0.9673 |
Hs 578T | Erlotinib | 0.12 | uM | LJP5 | 1 | M23 | 72 | hr | 765 | 3054 | 3140 | 0.9725 | 0.9728 |
Hs 578T | Erlotinib | 0.12 | uM | LJP5 | 2 | M23 | 72 | hr | 765 | 3108 | 3151 | 0.9862 | 0.9864 |
Hs 578T | Erlotinib | 0.12 | uM | LJP5 | 3 | M23 | 72 | hr | 765 | 3168 | 3152 | 1.0049 | 1.0048 |
Hs 578T | Erlotinib | 0.37 | uM | LJP5 | 1 | M22 | 72 | hr | 765 | 3038 | 3140 | 0.9674 | 0.9677 |
Hs 578T | Erlotinib | 0.37 | uM | LJP5 | 2 | M22 | 72 | hr | 765 | 3105 | 3151 | 0.9852 | 0.9855 |
Hs 578T | Erlotinib | 0.37 | uM | LJP5 | 3 | M22 | 72 | hr | 765 | 2954 | 3152 | 0.9371 | 0.9374 |
Hs 578T | Erlotinib | 1.11 | uM | LJP5 | 1 | M21 | 72 | hr | 765 | 2962 | 3140 | 0.9432 | 0.9434 |
Hs 578T | Erlotinib | 1.11 | uM | LJP5 | 2 | M21 | 72 | hr | 765 | 2835 | 3151 | 0.8995 | 0.8990 |
Hs 578T | Erlotinib | 1.11 | uM | LJP5 | 3 | M21 | 72 | hr | 765 | 2987 | 3152 | 0.9475 | 0.9479 |
Hs 578T | Erlotinib | 3.33 | uM | LJP5 | 1 | M20 | 72 | hr | 765 | 2784 | 3140 | 0.8865 | 0.8852 |
Hs 578T | Erlotinib | 3.33 | uM | LJP5 | 2 | M20 | 72 | hr | 765 | 2809 | 3151 | 0.8913 | 0.8904 |
Hs 578T | Erlotinib | 3.33 | uM | LJP5 | 3 | M20 | 72 | hr | 765 | 2963 | 3152 | 0.9399 | 0.9402 |